{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:04:31Z","timestamp":1792807471198,"version":"4.5.0"},"reference-count":135,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The appearance of antibiotic drugs revolutionized the possibilities for treatment of diseases with high mortality such as pneumonia, sepsis, plaque, diphtheria, tetanus, typhoid fever, and tuberculosis. Today fewer than 1% of mortalities in high income countries are caused by diseases caused by bacteria. However, it should be recalled that the antibiotics were introduced in parallel with sanitation including sewerage, piped drinking water, high standard of living and improved understanding of the connection between food and health. Development of salvarsan, sulfonamides, and \u03b2-lactams into efficient drugs is described. The effects on life expectancy and life quality of these new drugs are indicated.<\/jats:p>","DOI":"10.3390\/molecules26196057","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T21:23:55Z","timestamp":1633728235000},"page":"6057","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Drugs That Changed Society: History and Current Status of the Early Antibiotics: Salvarsan, Sulfonamides, and \u03b2-Lactams"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5773-6874","authenticated-orcid":false,"given":"S\u00f8ren Br\u00f8gger","family":"Christensen","sequence":"first","affiliation":[{"name":"The Museum of Natural Medicine & The Pharmacognostic Collection, University of Copenhagen, Jagtvej 162, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"ref_1","unstructured":"Koefoed, M. (1905). Befolkningsforholdene i Danmark, Statens Stistiske Buerau."},{"key":"ref_2","unstructured":"Christensen, G. (2017). D\u00f8den Skifter \u00c5rsag, Dansk Sygeplejehistoriske Museum."},{"key":"ref_3","unstructured":"Singer, C., and Underwood, E.A. (1962). A Short History of Medicine, Clarendon Press. [2nd ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.14219\/jada.archive.1997.0238","article-title":"Biofilms, microbial ecology and Antoni van Leeuwenhoek","volume":"128","author":"Slavkin","year":"1997","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"M\u00f6lleri, T.N. (1786). Animalcula Infusoria Fluviatilia er Marina, Hauni\u00e6.","DOI":"10.5962\/bhl.title.47041"},{"key":"ref_6","unstructured":"Pasteur, L. (1873). \u00c9tude sur le Vin, Librairie F. Savy. [2nd ed.]."},{"key":"ref_7","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"1","author":"Warren","year":"1983","journal-title":"Lancet"},{"key":"ref_8","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","volume":"1","author":"Marshall","year":"1983","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.dld.2006.06.013","article-title":"The history of Helicobacter pylori: A reflection on the relationship between the medical community and industry","volume":"38","author":"Ciacci","year":"2006","journal-title":"Dig. Liver Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1098\/rstb.2001.0888","article-title":"Risk factors for human disease emergence","volume":"356","author":"Taylor","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_12","first-page":"323","article-title":"The philosphy of hygiene","volume":"1","author":"Sigerist","year":"1933","journal-title":"Bull. Inst. Hist. Med."},{"key":"ref_13","unstructured":"Abell\u00e1n, J. (2017, January 2\u20133). Water supply and sanitation services in modern Europe: Developments in 19th\u201320th centuries. Proceedings of the XII International Congress of the Spanish Associations of Ecnonomic History, Salamanaca, Spain."},{"key":"ref_14","first-page":"17","article-title":"The Importance of Clean Water","volume":"1","author":"Khalifa","year":"2018","journal-title":"Sch. J. Appl. Sci. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: Advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discovery"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1021\/acs.chemrev.0c00922","article-title":"Ethnobotany and the Role of Plant Natural Products in Antibiotic Drug Discovery","volume":"121","author":"Porras","year":"2021","journal-title":"Chem. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural Products as Sources of New Drugs over the Nearly Four Decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000087453","article-title":"From Atoxyl to Salvarsan: Searching for the magic bullet","volume":"51","author":"Riethmiller","year":"2005","journal-title":"Chemotherapy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/00275514.1947.12017635","article-title":"What is an antibiotic or an antibiotic substance?","volume":"39","author":"Waksman","year":"1947","journal-title":"Mycologia"},{"key":"ref_20","first-page":"242","article-title":"Anti-infective drugs through medicinal chemistry: A 50-year retrospective","volume":"Volume 50","author":"Desai","year":"2015","journal-title":"2015 Medicinal Chemistry Reviews"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00134-017-4878-x","article-title":"Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: A visionary approach","volume":"43","author":"Bassetti","year":"2017","journal-title":"Intensive Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Marko, V. (2020). From Aspitin to Viagara, Springer Nature.","DOI":"10.1007\/978-3-030-44286-6"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM191103161641103","article-title":"Report of a series of cases of syphilis terated by Ehrlich\u2019s arsenobenzol at the Walter Reed General Hospital Distict of Columbia","volume":"164","author":"Jones","year":"1911","journal-title":"Boston Med. Surg. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/anie.200461471","article-title":"The composition of Ehrlich\u2019s salvarsan: Resolution of a century-old debate","volume":"44","author":"Lloyd","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMp048021","article-title":"Perspective: Paul Ehrlich\u2019s magic bullets","volume":"350","author":"Schwartz","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Christensen, S.B. (2021). Natrual Products that Changed Society. Biomedicines, 9.","DOI":"10.3390\/biomedicines9050472"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lesch, J.E. (2007). The First Miracle Drugs. How the Sulfa Drugs Transformed Medicine, Oxford University Press.","DOI":"10.1093\/oso\/9780195187755.001.0001"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0028-1129486","article-title":"Ein Beitrag zur Chemotherapie der bakteriellen Infektionen","volume":"61","author":"Domagk","year":"1935","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-0028-1129487","article-title":"Pontosil bei Streptokokkenkrankungen","volume":"61","author":"Klee","year":"1935","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.12968\/hmed.2009.70.8.43543","article-title":"The last year before the dawn of antibiotics","volume":"70","author":"Ellis","year":"2009","journal-title":"Br. J. Hosp. Med."},{"key":"ref_31","first-page":"756","article-title":"Activit\u00e9 du p-aminoph\u00e9nylsulfamide sur les infecti\u00f3ns streptococciques enxp\u00e9rimentales de la souris du lapin","volume":"120","author":"Trefouel","year":"1935","journal-title":"C. R. Seances Soc. Biol. Ses. Fil."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(00)48181-X","article-title":"The mode of action of p-aminobenzenesulfonamide and Prontosil in h\u00e6molytic streptococcal infections","volume":"228","author":"Colebrook","year":"1936","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)97447-6","article-title":"Is p-aminobenzenesulphonamide the active agent in prontosil therapy?","volume":"229","author":"Fuller","year":"1937","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Loudon, I. (1992). Maternal Care and Maternal Mortality in Britain, 1935\u20131950. Death in Childbirth: An International Study of Maternal Care and Maternal Mortality 1800\u20131950, Oxford University Press.","DOI":"10.1093\/acprof:oso\/9780198229971.003.0016"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(00)72741-3","article-title":"A rational approach to research in chemotherapy","volume":"238","author":"Fildes","year":"1940","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.2174\/1389557520666200905125738","article-title":"From Antibacterial to Antitumour Agents: A Brief Review on The Chemical and Medicinal Aspects of Sulfonamides","volume":"20","author":"Dias","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Dewick, P.M. (2009). Medicinal Natural Products, John Wiley and Sons Ltd.. [3rd ed.].","DOI":"10.1002\/9780470742761"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"112829","DOI":"10.1016\/j.ejmech.2020.112829","article-title":"\u03b2-Lactam antibiotics: An overview from a medicinal chemistry perspective","volume":"208","author":"Lima","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ji, Y. (2020). Clinical, Epidemiologic, and Laboratory Aspects of Methicillin-Resistant Staphylococcus aureus Infections. Cutting-Edge Technologies and Advancements. Methicillin-Resistant Staphylococcus aureus (MRSA) Protocols, Humana Press. [3rd ed.].","DOI":"10.1007\/978-1-4939-9849-4"},{"key":"ref_40","first-page":"226","article-title":"The antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenz\u00e6","volume":"10","author":"Fleming","year":"1929","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08941939.2012.664099","article-title":"History of antibiotics. From salvarsan to cephalosporins","volume":"25","author":"Zaffiri","year":"2012","journal-title":"J. Investig. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0968-0004(91)90076-8","article-title":"Early discoveries in the penicillin series","volume":"16","author":"Nayler","year":"1991","journal-title":"Trends Biochem. Sci."},{"key":"ref_43","unstructured":"Brunton, L.L. (2011). Penicillins, cephalosporins, and other beta-lactam antibiotics. Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics, McGraw Hill Medicinal. [12th ed.]."},{"key":"ref_44","first-page":"277","article-title":"The b-Lactam Antibiotics","volume":"Volume 4","author":"Wolff","year":"1997","journal-title":"Burger\u2019s Medicinal Chemistry and Drug Discovery"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.1021\/cr4005549","article-title":"Chemical Synthesis of \u03b2-Lactams: Asymmetric Catalysis and Other Recent Advances","volume":"114","author":"Pitts","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_46","first-page":"27","article-title":"Fra L\u00f8vens Kemiske Fabrik til Leo Pharma A\/S","volume":"36","year":"2005","journal-title":"Theriaca"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"(1945). Chemistry of Penicilin. Nature, 156, 766\u2013767.","DOI":"10.1038\/156766a0"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Council T.C.o.M.R.a.T.M.R. (1945). Chemistry of Penicillin. Science, 102, 627\u2013629.","DOI":"10.1126\/science.102.2660.627"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/anie.200460864","article-title":"Chasing molecules that were never there: Misassigned natural products and the role of chemical synthesis in modern structure elucidation","volume":"44","author":"Nicolaou","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_50","first-page":"85","article-title":"X-ray analysis of the structure of penicillin","volume":"6","author":"Hodgkin","year":"1949","journal-title":"Adv. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1098\/rstb.1980.0042","article-title":"Penems and related substances","volume":"289","author":"Woodward","year":"1980","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/acs.chemrev.0c01010","article-title":"b-Lactams against the Fortress of the Gram-Positive Staphylococcus aureus Bacterium","volume":"121","author":"Fisher","year":"2021","journal-title":"Chem. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1021\/acs.joc.1c01110","article-title":"Evaluation of Cyclic Amides as Activating Groups in N\u2212C Bond Cross-Coupling: Discovery of N-Acyl-\u03b4-valerolactams as Effective Twisted Amide Precursors for Cross-Coupling Reactions","volume":"86","author":"Rahman","year":"2021","journal-title":"J. Org. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jmb.2008.01.047","article-title":"The Last Step in Cephalosporin C Formation Revealed: Crystal Structures of Deacetylcephalosporin C Acetyltransferase from Acremonium chrysogenum in Complexes with Reaction Intermediates","volume":"377","author":"Lejon","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/41.6.589","article-title":"Forty years of \u03b2-lactam research","volume":"41","author":"Rolinson","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/183257b0","article-title":"Synthesis of penicillin-6-aminopenicillanic acid in penicillin fermentations","volume":"183","author":"Batchelor","year":"1959","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0968-0004(91)90092-A","article-title":"Semi-synthetic approaches to novel penicillins","volume":"16","author":"Nayler","year":"1991","journal-title":"Trends Biochem. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4155\/fmc-2016-0078","article-title":"The road to avibactam: The first clinically useful non-\u03b2-lactam working somewhat like a \u03b2-lactam","volume":"8","author":"Wang","year":"2016","journal-title":"Future Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1073\/pnas.54.4.1133","article-title":"Mechanism of action of penicillins; a proposal based on their structural similarity to acyl-D-alanyl-D-alanine","volume":"54","author":"Tipper","year":"1965","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/prot.10450","article-title":"Understanding the acylation mechanisms of active-site serine penicillin-recognizing proteins: A molecular dynamics simulation study","volume":"53","author":"Oliva","year":"2003","journal-title":"Proteins Struct. Funct. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1021\/ja00746a057","article-title":"6-Methyl penicillins and 7-methyl cephalosporins","volume":"93","author":"Boehme","year":"1971","journal-title":"J. Amer. Chem. Soc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1271\/nogeikagaku1924.23.411","article-title":"A new enzyme, penicillin-amidase. Preliminary","volume":"23","author":"Sakaguchi","year":"1950","journal-title":"Nippon Nogei Kagaku Kaishi"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(61)90174-X","article-title":"A new synthetic penicillin PA-248","volume":"1","author":"Williamson","year":"1961","journal-title":"Lancet"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(61)90176-3","article-title":"Clinical use of a new synthetic penicillin: PA-248","volume":"1","author":"Nagley","year":"1961","journal-title":"Lancet"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1093\/clinids\/14.Supplement_2.S218","article-title":"Streptococcal pharyngitis: Current therapy and criteria for evaluation of new agents","volume":"14","author":"Peter","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1176667","article-title":"Antibiotics for Emerging Pathogens","volume":"325","author":"Fischbach","year":"2009","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijantimicag.2006.09.003","article-title":"The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA)","volume":"29","author":"Rolinson","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/514920","article-title":"Antibiotic resistance caused by Gram-negative multidrug efflux pumps","volume":"27","author":"Nikaido","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/146837a0","article-title":"An enzyme from bacteria able to destroy penicillin","volume":"146","author":"Abraham","year":"1940","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Ogawara, H. (2016). Self-resistance in Streptomyces, with special reference to \u03b2-lactam antibiotics. Molecules, 21.","DOI":"10.3390\/molecules21050605"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(65)90004-8","article-title":"Resistance to Penicillins and its transfer in enterobacteriaceae","volume":"1","author":"Anderson","year":"1965","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/anie.202006635","article-title":"Fluorogenic Probes\/Inhibitors of \u03b2-Lactamase and their Applications in Drug-Resistant Bacteria","volume":"60","author":"Ding","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature10388","article-title":"Antibiotic resistance is ancient","volume":"477","author":"King","year":"2011","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1098\/rstb.1980.0049","article-title":"The structure of \u03b2-lactamases","volume":"289","author":"Ambler","year":"1980","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/208239a0","article-title":"Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae","volume":"208","author":"Datta","year":"1965","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000238634","article-title":"Induction potency of various beta-lactam derivatives in gram-negative rods","volume":"35","author":"Cullmann","year":"1989","journal-title":"Chemotherapy"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1021\/acs.accounts.0c00863","article-title":"Designing Inhibitors of \u03b2-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria","volume":"54","author":"Davies","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"De Araujo Viana Marques, D., Machado, S.E.F., Ebinuma, V.C.S., de Albuquerque Lima Duarte, C., Converti, A., and Porto, A.L.F. (2018). Production of \u03b2-lactamase inhibitors by Streptomyces species. Antibiotics, 7.","DOI":"10.3390\/antibiotics7030061"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Doyle, F.P., Hardy, K., Nayler, J.H.C., Soulal, M.J., Stove, E.R., and Waddington, H.R.J. (1962). Derivatives of 6-aminopenicillanic acid. III. 2,6-Dialkoxybenzoyl derivatives. J. Chem. Soc., 1453\u20131458.","DOI":"10.1039\/jr9620001453"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jiac.2019.10.023","article-title":"Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: A retrospective cohort study","volume":"26","author":"Moriyama","year":"2020","journal-title":"J. Infect. Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/clind\/15.5.824","article-title":"Beta-Lactam resistance in gram-negative bacteria: Global trends and clinical impact","volume":"15","author":"Sanders","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/ja00788a071","article-title":"Direct 6-methoxylation of penicillin derivatives. A convenient pathway to substituted -lactam antibiotics","volume":"95","author":"Baldwin","year":"1973","journal-title":"J. Am. Chem. Soc."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.26.5.734","article-title":"In vitro antibacterial properties of BRL 36650, a novel 6\u03b1-substituted penicillin","volume":"26","author":"Basker","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/acs.jmedchem.0c01516","article-title":"A Decade of FDA-Approved Drugs (2010\u20132019): Trends and Future Directions","volume":"64","author":"Brown","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_85","unstructured":"Murakami, M., Takahashi, K., Isaka, I., Kawahara, N., Horiguchi, H., Murakami, Y., Sakamoto, N., Ozasa, T., Kashiwagi, T., and Nakano, K. (1973). New Oxymethylester Derivatives of Penicillin and Cephalosporin. (DE2228670A1), German Patent."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/AAC.6.5.563","article-title":"Clinical pharmacology of pivampicillin","volume":"6","author":"Roholt","year":"1974","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/pgmj.68.805.932","article-title":"Carnitine deficiency associated with long-term pivampicillin treatment: The effect of a replacement therapy regime","volume":"68","author":"Rose","year":"1992","journal-title":"Postgrad. Med. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1128\/AAC.5.6.670","article-title":"BRL.8988 (Talampicillin), a well-absorbed oral form of ampicillin","volume":"5","author":"Clayton","year":"1974","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/AAC.15.4.510","article-title":"Bacampicillin, ampicillin, cephalothin and cephapirin levels in human blood and interstitial fluid","volume":"15","author":"Tan","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_90","first-page":"172","article-title":"Ampicillin concentrations in human serum and oral tissues following a single oral administration of lenampicillin","volume":"42","author":"Omata","year":"1994","journal-title":"Chemotherapy"},{"key":"ref_91","unstructured":"Flynn, E.H. (1972). Cephalosporin C. Cephalosporins and Penicillins, Princeton University Press."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/175548a0","article-title":"Cephalosporin C, a new antibiotic containing sulfur and D-\u03b1-aminoadipic acid","volume":"175","author":"Newton","year":"1955","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj0790377","article-title":"Structure of cephalosporin C","volume":"79","author":"Abraham","year":"1961","journal-title":"Biochem. J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/bj0790393","article-title":"The X-ray analysis of the structure of cephalosporin C","volume":"79","author":"Hodgkin","year":"1961","journal-title":"Biochem. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/ja00895a063","article-title":"Chemistry of cephalosporin antibiotics. III. Chemical correlation of penicillin and cephalosporin antibiotics","volume":"85","author":"Morin","year":"1963","journal-title":"J. Am. Chem. Soc."},{"key":"ref_96","unstructured":"Lucinova, E., Welward, L., Frimm, R., Kosalko, R., and Sokol, M. (1979). 7-Aminocephalosporanic Acid. (CS193181B1), Czech Patent."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.22207\/JPAM.10.4.03","article-title":"Cephalosporin C acylase from microbes for one-step enzymatic transformation of cephalosporin C to 7-aminocephalosporanic acid","volume":"10","author":"Hardianto","year":"2016","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref_98","first-page":"28","article-title":"Chemistry, classification, pharmacokinetics, clinical uses and analysis of beta lactam antibiotics: A review","volume":"6","author":"Masoud","year":"2014","journal-title":"J. Chem. Pharm. Res."},{"key":"ref_99","first-page":"17877","article-title":"Cephalosporins: A Review on Imperative Class of Antibiotics","volume":"2016","author":"Mehta","year":"2016","journal-title":"Inventi Rapid Mol. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/AAC.00645-09","article-title":"Comparative pharmacokinetics of ceftaroline in rats, rabbits, and monkeys following a single intravenous or intramuscular injection","volume":"54","author":"Ge","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: Past, present, and future","volume":"55","author":"Endimiani","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/AAC.22.1.62","article-title":"Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase-I","volume":"22","author":"Kropp","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1973947812Y.0000000032","article-title":"Carbapenems","volume":"25","author":"Breilh","year":"2013","journal-title":"J. Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/AAC.36.7.1577","article-title":"Stability of meropenem and effect of 1\u03b2-methyl substitution on its stability in the presence of renal dehydropeptidase I","volume":"36","author":"Fukasawa","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/jo01294a042","article-title":"Thienamycin total synthesis. 1. Synthesis of azetidinone precursors of (\u00b1)-thienamycin and its stereoisomers","volume":"45","author":"Bouffard","year":"1980","journal-title":"J. Org. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1021\/jo01294a043","article-title":"Thienamycin total synthesis. 2. Model studies-synthesis of a simple 2-(alkylthio)carbapen-2-em","volume":"45","author":"Schmitt","year":"1980","journal-title":"J. Org. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/jo01294a044","article-title":"Thienamycin total synthesis. 3. Total synthesis of (\u00b1)-thienamycin and (\u00b1)-8-epithienamycin","volume":"45","author":"Schmitt","year":"1980","journal-title":"J. Org. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1021\/ja00526a048","article-title":"Studies on the syntheses of heterocyclic compounds. 800. A formal total synthesis of (\u00b1)-thienamycin and a (\u00b1)-decysteaminylthienamycin derivative","volume":"102","author":"Kametani","year":"1980","journal-title":"J. Am. Chem. Soc."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0040-4020(95)00842-X","article-title":"Preparations of two pivotal intermediates for the synthesis of 1-\u03b2-methyl carbapenem antibiotics","volume":"52","author":"Berks","year":"1996","journal-title":"Tetrahedron"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2017.03.022","article-title":"Recent updates of carbapenem antibiotics","volume":"131","author":"Brahim","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Cotroneo, N., Rubio, A., Critchley, I.A., Pillar, C., and Pucci, M.J. (2020). In vitro and in vivo characterization of tebipenem, an oral carbapenem. Antimicrob. Agents Chemother., 64.","DOI":"10.1128\/AAC.02240-19"},{"key":"ref_112","first-page":"339","article-title":"Synthesis of Faropenem","volume":"32","author":"Han","year":"2001","journal-title":"Zhongguo Yiyao Gongye Zazhi"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1021\/jo00042a010","article-title":"2-Thioalkyl penems: An efficient synthesis of sulopenem, a (5R,6S)-6-(1(R)-hydroxyethyl)-2-[(cis-1-oxo-3-thiolanyl)thio]-2-penem antibacterial","volume":"57","author":"Volkmann","year":"1992","journal-title":"J. Org. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/39.1.35","article-title":"The in-vitro activity of faropenem, a novel oral penem","volume":"39","author":"Woodcock","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/14787210.5.2.185","article-title":"Faropenem: Review of a new oral penem","volume":"5","author":"Schurek","year":"2007","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/289590a0","article-title":"Sulfazecin and isosulfazecin, novel \u03b2-lactam antibiotics of bacterial origin","volume":"289","author":"Imada","year":"1981","journal-title":"Nature"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/8.suppl_E.1","article-title":"Monobactams-monocyclic \u03b2-lactam antibiotics produced by bacteria","volume":"8","author":"Sykes","year":"1981","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/jac\/dkw231","article-title":"A review of the pharmacokinetics and pharmacodynamics of aztreonam","volume":"71","author":"Ramsey","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12275-020-0285-z","article-title":"Recent advances in the development of \u03b2-lactamase inhibitors","volume":"58","author":"Jalde","year":"2020","journal-title":"J. Microbiol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Yahav, D., Giske, C.G., Graematniece, A., Abodakpi, H., Tam, V.H., and Leibovici, L. (2021). New \u03b2-Lactam-\u03b2-Lactamase Inhibitor Combinations. Clin. Microbiol. Rev., 34.","DOI":"10.1128\/CMR.00021-21"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7164\/antibiotics.29.668","article-title":"Naturally occurring \u03b2-lactamase inhibitors with antibacterial activity","volume":"29","author":"Brown","year":"1976","journal-title":"J. Antibiot."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Howarth, T.T., Brown, A.G., and King, T.J. (1976). Clavulanic acid, a novel \u03b2-lactam isolated from Streptomyces clavuligerus; X-ray crystal structure analysis. J. Chem. Soc. Chem. Commun., 266\u2013267.","DOI":"10.1039\/C3976000266B"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bcp.2005.11.012","article-title":"Understanding the longevity of the \u03b2-lactam antibiotics and of antibiotic\/\u03b2-lactamase inhibitor combinations","volume":"71","author":"Buynak","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1016\/S0040-4039(00)85439-8","article-title":"Structure of lactivicin, an antibiotic having a new nucleus and similar biological activities to \u03b2-lactam antibiotics","volume":"27","author":"Harada","year":"1986","journal-title":"Tetrahedron Lett."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/325179a0","article-title":"Binding of a non-\u03b2-lactam antibiotic to penicillin-binding proteins","volume":"325","author":"Nozaki","year":"1987","journal-title":"Nature"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/pauz.200790103","article-title":"Lactivicin\u2014An antibiotic against penicillin-resistant pneumococci","volume":"36","author":"Holzgrabe","year":"2007","journal-title":"Pharm. Unserer Zeit"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1185\/03007995.2012.748653","article-title":"Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: Results of a prospective, investigator-blinded, randomized study","volume":"28","author":"Vazquez","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1021\/acs.jmedchem.1c00369","article-title":"6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to \u03b2-Lactam Antibiotics","volume":"64","author":"Rodriguez","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s40265-018-0966-7","article-title":"Meropenem\/Vaborbactam: A Review in Complicated Urinary Tract Infections","volume":"78","author":"Dhillon","year":"2018","journal-title":"Drugs"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bmc.2007.10.075","article-title":"Structure-based optimization of cephalothin-analogue boronic acids as \u03b2-lactamase inhibitors","volume":"16","author":"Morandi","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1517\/14656566.2015.983077","article-title":"Clinical, economic and societal impact of antibiotic resistance","volume":"16","author":"Barriere","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/605630","article-title":"Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: Implications for antibiotic stewardship","volume":"49","author":"Roberts","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","article-title":"10 \u00d7 \u203220 Progress\u2014Development of new drugs active against gram-negative bacilli: An update from the Infectious Diseases Society of America","volume":"56","author":"Boucher","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bcp.2016.09.025","article-title":"Antibiotics in late clinical development","volume":"133","author":"Fernandes","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_135","first-page":"1","article-title":"The economic value of vaccination: Why prevention is wealth","volume":"3","author":"Remy","year":"2015","journal-title":"J. Mark. Access Health Policy"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/19\/6057\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:10:03Z","timestamp":1760166603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/19\/6057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":135,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["molecules26196057"],"URL":"https:\/\/doi.org\/10.3390\/molecules26196057","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]}}}